| scholarly article | Q13442814 |
| P50 | author | Xiao-Yi Zeng | Q59681783 |
| Hao Wang | Q59693997 | ||
| Stanley Chan | Q79859597 | ||
| P2093 | author name string | Matthew J Watt | |
| Ji-Ming Ye | |||
| Ruo-Qiong Sun | |||
| Zi-Heng Choong | |||
| P2860 | cites work | Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle | Q54986901 |
| Measurement of rates of cholesterol synthesis using tritiated water | Q70767427 | ||
| Use of a selective inhibitor of liver carnitine palmitoyltransferase I (CPT I) allows quantification of its contribution to total CPT I activity in rat heart. Evidence that the dominant cardiac CPT I isoform is identical to the skeletal muscle enzym | Q72724639 | ||
| Influence of PPAR-alpha agonist fenofibrate on insulin sensitivity and selected adipose tissue-derived hormones in obese women with type 2 diabetes | Q79446686 | ||
| Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1 | Q22011167 | ||
| Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting | Q24563197 | ||
| Endoplasmic reticulum stress and the inflammatory basis of metabolic disease | Q24633352 | ||
| Identification of a physiologically relevant endogenous ligand for PPARalpha in liver | Q24653691 | ||
| The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling | Q27008029 | ||
| Signal integration in the endoplasmic reticulum unfolded protein response | Q27860577 | ||
| A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders | Q28116120 | ||
| Biochemistry of mammalian peroxisomes revisited | Q28244563 | ||
| Role of fructose-containing sugars in the epidemics of obesity and metabolic syndrome | Q28251719 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes | Q28575190 | ||
| Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice | Q28593025 | ||
| IKK-beta links inflammation to obesity-induced insulin resistance | Q29614285 | ||
| Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 | Q29615209 | ||
| Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes | Q29615503 | ||
| Mechanisms for insulin resistance: common threads and missing links | Q29620447 | ||
| Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice | Q30513404 | ||
| Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice | Q33553422 | ||
| Fenofibrate: a review of its lipid-modifying effects in dyslipidemia and its vascular effects in type 2 diabetes mellitus | Q33933474 | ||
| Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study | Q34113313 | ||
| Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance. | Q34166238 | ||
| Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors | Q34234016 | ||
| Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy | Q34237562 | ||
| Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes | Q34370610 | ||
| Lipid-induced insulin resistance: unravelling the mechanism | Q34370958 | ||
| Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation | Q34512108 | ||
| Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression | Q34563098 | ||
| Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators | Q35594983 | ||
| Dissociation of inositol-requiring enzyme (IRE1α)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice | Q35709954 | ||
| Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance | Q37105295 | ||
| GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice | Q37170811 | ||
| Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans | Q37170824 | ||
| Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways. | Q37363053 | ||
| A ceramide-centric view of insulin resistance | Q38007631 | ||
| Lipid-induced endoplasmic reticulum stress in liver cells results in two distinct outcomes: adaptation with enhanced insulin signaling or insulin resistance | Q39388424 | ||
| Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism | Q39928700 | ||
| Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. | Q40701074 | ||
| The unfolded protein response transducer IRE1α prevents ER stress-induced hepatic steatosis | Q41904044 | ||
| UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. | Q42041480 | ||
| Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate | Q42476162 | ||
| Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. | Q42508603 | ||
| Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway | Q42815451 | ||
| PERK (eIF2alpha kinase) is required to activate the stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasis | Q43226732 | ||
| Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation | Q43555551 | ||
| Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle | Q43990155 | ||
| Casitas b-lineage lymphoma-deficient mice are protected against high-fat diet-induced obesity and insulin resistance | Q46966521 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endoplasmic reticulum | Q79927 |
| insulin resistance | Q1053470 | ||
| steatosis | Q1365091 | ||
| P304 | page(s) | 2095-2105 | |
| P577 | publication date | 2013-01-24 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress | |
| P478 | volume | 62 |
| Q48049108 | A rich medium-chain triacylglycerol diet benefits adiposity but has adverse effects on the markers of hepatic lipogenesis and beta-oxidation. |
| Q64097026 | Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: is TMAO serving as a marker for hepatic insulin resistance |
| Q37594114 | Bilirubin increases insulin sensitivity in leptin-receptor deficient and diet-induced obese mice through suppression of ER stress and chronic inflammation |
| Q59449558 | Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance |
| Q36128458 | Characterization of the Mouse and Human Monoacylglycerol O-Acyltransferase 1 (Mogat1) Promoter in Human Kidney Proximal Tubule and Rat Liver Cells |
| Q49951009 | Chinese olive extract ameliorates hepatic lipid accumulation in vitro and in vivo by regulating lipid metabolism |
| Q36350768 | Chronic activation of PPARα with fenofibrate reduces autophagic proteins in the liver of mice independent of FGF21. |
| Q42315084 | Curcumin Improves Palmitate-Induced Insulin Resistance in Human Umbilical Vein Endothelial Cells by Maintaining Proteostasis in Endoplasmic Reticulum |
| Q37196514 | Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease |
| Q36392668 | Disparate metabolic response to fructose feeding between different mouse strains |
| Q36430763 | E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis. |
| Q60513161 | Effects of a Diet Rich in n-3 Polyunsaturated Fatty Acids on Hepatic Lipogenesis and Beta-Oxidation in Mice |
| Q40105326 | Evaluation of the In Vivo and In Vitro Effects of Fructose on Respiratory Chain Complexes in Tissues of Young Rats |
| Q43881454 | Evaluation of the effects of fructose on oxidative stress and inflammatory parameters in rat brain |
| Q42368231 | Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease. |
| Q49498180 | Fructose metabolism and metabolic disease |
| Q98471212 | Gynura divaricata exerts hypoglycemic effects by regulating the PI3K/AKT signaling pathway and fatty acid metabolism signaling pathway |
| Q55315063 | Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption. |
| Q58697160 | Hepatoprotective Effects of MHY3200 on High-Fat, Diet-Induced, Non-Alcoholic Fatty Liver Disease in Rats |
| Q36016417 | Identification of matrine as a promising novel drug for hepatic steatosis and glucose intolerance with HSP72 as an upstream target |
| Q46074650 | Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide |
| Q24564130 | Integrated physiology and systems biology of PPARα |
| Q64967941 | Inula L. Secondary Metabolites against Oxidative Stress-Related Human Diseases. |
| Q27015015 | Involvement of the IRE1α-XBP1 pathway and XBP1s-dependent transcriptional reprogramming in metabolic diseases |
| Q58698213 | Is Atorvastatin Associated with New Onset Diabetes or Deterioration of Glycemic Control? Systematic Review Using Data from 1.9 Million Patients |
| Q49843619 | Liver function and dysfunction - a unique window into the physiological reach of ER stress and the unfolded protein response |
| Q64093846 | Matrine Protects Against MCD-Induced Development of NASH via Upregulating HSP72 and Downregulating mTOR in a Manner Distinctive From Metformin |
| Q33616602 | Metabolic Impact of Light Phase-Restricted Fructose Consumption Is Linked to Changes in Hypothalamic AMPK Phosphorylation and Melatonin Production in Rats. |
| Q28818585 | Metabolomic Approaches to Explore Chemical Diversity of Human Breast-Milk, Formula Milk and Bovine Milk |
| Q38260582 | Molecular insights into the mechanisms of liver-associated diseases in early-lactating dairy cows: hypothetical role of endoplasmic reticulum stress |
| Q37062751 | Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease |
| Q51076739 | Naltrexone changes the expression of lipid metabolism-related proteins in the endoplasmic reticulum stress induced hepatic steatosis in mice. |
| Q35559692 | Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats |
| Q56507904 | Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison? |
| Q37670086 | Nuclear Receptors Resolve Endoplasmic Reticulum Stress to Improve Hepatic Insulin Resistance |
| Q101574061 | PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat |
| Q33832975 | PPARα-independent actions of omega-3 PUFAs contribute to their beneficial effects on adiposity and glucose homeostasis |
| Q33944254 | Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα. |
| Q37120406 | Peroxisome proliferator-activated receptor alpha acts as a mediator of endoplasmic reticulum stress-induced hepatocyte apoptosis in acute liver failure. |
| Q41457655 | Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease. |
| Q60301971 | Preconditioning lessens high fat induced metabolic syndrome along with markers of increased metabolic capacity in muscle and adipose tissue |
| Q50355591 | Reduced islet function contributes to impaired glucose homeostasis in fructose-fed mice |
| Q89450069 | Repurposing matrine for the treatment of hepatosteatosis and associated disorders in glucose homeostasis in mice |
| Q34709831 | Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients |
| Q53094807 | Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption. |
| Q38752520 | The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans |
| Q41816192 | The cardiometabolic benefits of glycine: Is glycine an 'antidote' to dietary fructose? |
| Q98623164 | The critical role of PPARα in the binary switch between life and death induced by endoplasmic reticulum stress |
| Q38825911 | The role of ER stress in lipid metabolism and lipotoxicity |
| Q37260526 | Zerumbone, a Natural Cyclic Sesquiterpene of Zingiber zerumbet Smith, Attenuates Nonalcoholic Fatty Liver Disease in Hamsters Fed on High-Fat Diet |
| Q37001018 | Zingiber mioga reduces weight gain, insulin resistance and hepatic gluconeogenesis in diet-induced obese mice |
| Q41195914 | eIF2α phosphorylation is required to prevent hepatocyte death and liver fibrosis in mice challenged with a high fructose diet |
Search more.